Journals / Gülhane Tıp Dergisi / 2011 / Cilt: 53 - Sayı: 3

Hydrops fetalis due to Kell alloimmunization: a case report

Kell alloimmünizasyonuna bağlı hidrops fetalis: olgu sunumu

Pages
219–222
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case report fetal and neonatal hemolytic disease occuring due to Kell izoimmunization is discussed under the light of literature knowledge regarding a case of hydrops fetalis developing due to sensitization with anti-Kell antibodies and resulting in utero excitus despite intensive follow-up and treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kell alloimmunization is one of the rare but at the same time most frequent causes of hemolytic disease of fetus and newborn after anti-D alloimmunization.
📊
Key Findings & Data:Management of Kell alloimmunization which uniquely demonstrates its effect via the supression of fetal erythropoietic response is somewhat different from alloimmunization occuring due to RhD antibodies.
💡
Conclusion & Impact:In this case report fetal and neonatal hemolytic disease occuring due to Kell izoimmunization is discussed under the light of literature knowledge regarding a case of hydrops fetalis developing due to sensitization with anti-Kell antibodies and resulting in utero excitus despite intensive follow-up and treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Kell alloimmunization is one of the rare but at the same time most frequent causes of hemolytic disease of fetus and newborn after anti-D alloimmunization. Management of Kell alloimmunization which uniquely demonstrates its effect via the supression of fetal erythropoietic response is somewhat different from alloimmunization occuring due to RhD antibodies. In this case report fetal and neonatal hemolytic disease occuring due to Kell izoimmunization is discussed under the light of literature knowledge regarding a case of hydrops fetalis developing due to sensitization with anti-Kell antibodies and resulting in utero excitus despite intensive follow-up and treatment.

Özet

Kell alloimmünizasyonu, fetal ve yenidoğan hemolitik hastalığının anti-D alloimmünizasyonundan sonra en sık izlenen, fakat aynı zamanda nadir rastlanılan nedenlerinden birisidir. Kendine has özelliği ile fetal eritropoetik cevabın baskılanması üzerinden etki eden Kell alloimmünizasyonunun yönetimi RhD antikorları ile oluşan alloimmünizasyondan biraz farklıdır. Bu yazıda anti-Kell antikorları ile sensitizasyon sonucunda oluşan hidrops fetalis ve yoğun tedavi-takibe rağmen in-utero eksitus ile sonuçlanan bir olgu nedeni ile Kell izoimmünizasyonuna bağlı olarak oluşan fetal ve yenidoğan hemolitik hastalığı mevcut literatür bilgisi ışığında tartışılmıştır.

🔖

Cite This Article

BODUR, S., TÜTÜNCÜ, L., ERDEM, G. (2011). Hydrops fetalis due to Kell alloimmunization: a case report. Gülhane Tıp Dergisi, Cilt: 53 - Sayı: 3, 219–222. https://ajindex.com/articles/225378

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: a continuing problem. Clin Obstet Gynecol 1982; 25: 321-332
  2. Wenk RE, Goldstein, P, Felix JK. Kell alloimmunization, hemolytic disease of the newborn, and perinatal management. Obstet Gynecol 1985; 66: 473-476
  3. Pepperell RJ, Barrie JU, Fliegner JR. Significance of redcell irregular antibodies in the obstetric patient. Med J Aust 1977; 2: 453-456
  4. Filbey D, Hanson U, Wesstrom G. The prevalence of red cell antibodies in pregnancy correlated to the outcome of the newborn: a 12 year study in central Sweden. Acta Obstet Gynecol Scand 1995; 74: 687-692
  5. Moise KJ Jr. Non-anti-D antibodies in red-cell alloimmunization. Eur J Obstet Gynecol Reprod Biol 2000; 92: 75-81
  6. Vaughan JI, Manning M, Warwick RM, et al. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998; 338: 798-803
  7. Vaughan JI, Warwick R, Letsky E, et al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994; 171: 247-252
  8. Berkowitz RL, Beyth Y, Sadovsky E. Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid. Obstet Gynecol 1982; 60: 746-749
  9. Bowman JM. Treatment options for the fetus with alloimmune hemolytic disease. Transfus Med Rev 1990; 4: 191-207
  10. Weiner CP, Widness JA. Decreased fetal erythropoiesis and hemolysis in Kell hemolytic anemia. Am J Obstet Gynecol 1996; 174: 547-551
  11. Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborate Group for Doppler Assessment of Blood Velocity in Anemic Fetuses. N Engl J Med 2000; 342: 9-14. 12. van Dongen H, Klumper FJ, Sikkel E, et al. Non-invasive tests to predict fetal anemia in Kell-alloimmunized pregnancies. Ultrasound Obstet Gynecol 2005; 25: 341-345
  12. Collinet P, Subtil D, Puech F, et al. Successful treatment of extremely severe fetal anemia due to Kell alloimmunization. Obstet Gynecol 2002; 100: 1102-1105
  13. Dhodapkar KM, Blei F. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin. J Pediatr Hematol Oncol 2001; 23: 69-70.